choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • AtriCure Clinical Trials

AtriCure Clinical Trials Newsletter
  • AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript 16 Feb 2024 16:37 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … Afib diagnosis through our LeAAPS clinical trial. The LeAAPS trial seeks … and expansion of our LeAAPS clinical trial and multiple product development …

  • AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results 15 Feb 2024 21:10 GMT

    … driven by investments in clinical trials and product development initiatives outpacing … following the presentation. About AtriCure AtriCure, Inc. provides innovative technologies … Financial Measures To supplement AtriCure’s condensed consolidated financial …

  • Head-To-Head Comparison: AtriCure (NASDAQ:ATRC) and NovoCure (NASDAQ:NVCR) 10 Dec 2023 17:24 GMT

    … NovoCure is more favorable than AtriCure. Summary AtriCure beats NovoCure on 10 … also has ongoing or completed clinical trials investigating TTFields in brain metastases … Helier, Jersey. About AtriCure (Get Free Report) AtriCure, Inc. develops, manufactures …

  • AtriCure Releases 2023 ESG Report 14 Nov 2023 13:21 GMT

    … amp;I) practices. Launching key clinical trials and research studies focused on … employee learning and development. AtriCure created unique opportunities for educational … to view the report. About AtriCure AtriCure, Inc. provides innovative technologies for …

  • AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript 02 Nov 2023 19:21 GMT

    … Call Transcript November 1, 2023 AtriCure, Inc. beats earnings expectations. … approvals, clearances, reimbursement and clinical trial outcomes. A healthcare professional examining … materially from those projected. AtriCure undertakes no obligation to publicly …

  • AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial 31 Jan 2023 13:10 GMT

    … , investigational device exemption (IDE) clinical trial to evaluate the safety and … atrial fibrillation and stroke.” About AtriCure AtriCure, Inc. provides innovative technologies … of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation …

  • AtriCure, Inc. (NASDAQ:ATRC) Q2 2023 Earnings Call Transcript 28 Jul 2023 18:45 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … devices through the groundbreaking LeAAPS clinical trial. With two-thirds of the … investment in the HEAL-IST clinical trial in a dedicated IST clamp …

  • AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial 07 Jun 2022 12:33 GMT

    AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was treated in the …

  • AtriCure, Inc. (NASDAQ:ATRC) Q4 2022 Earnings Call Transcript 24 Feb 2023 00:26 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ … contemplates heavy enrollment within our clinical trials as more sites activate … the lens of clinical trial — real expansion of the clinical trials and a …

  • AtriCure treats first patient in stroke prevention trial 01 Feb 2023 03:04 GMT

    … AtriClip. Mason, Ohio-based AtriCure designed AtriClip for the … make it the largest randomized clinical trial for surgical LAA exclusion, … , president and CEO of AtriCure. Carrel added that the … also allows AtriCure to expand its markets. AtriCure plans to …

Satisfied with the content?

Continue to create your account.